Three Cases of COVID-19 Pneumonia That Responded to Icosapent Ethyl Supportive Treatment

Winston Suh; Ivan Urits; Omar Viswanath; Alan D. Kaye; Haresh Patel; Wade Hall; Jonathan P. Eskander

doi:10.12659/AJCR.928422

14 December 2020 : Case report USA

Three Cases of COVID-19 Pneumonia That Responded to Icosapent Ethyl Supportive Treatment

Unusual or unexpected effect of treatment

Winston Suh^1DEF*, Ivan Urits^2DEF, Omar Viswanath^1345DEF, Alan D. Kaye^1DEF, Haresh Patel^6DEF, Wade Hall^7DEF, Jonathan P. Eskander^8DEF

DOI: 10.12659/AJCR.928422

Am J Case Rep 2020; 21:e928422

Authors information Article notes Copyright and License information

Related articles Order reprints Share article Share by email

View HTML version

Table 2. Inpatient laboratory results (case 2).

	7/3	7/4	7/5	7/6	7/7	7/8	7/9	7/10	7/12	7/24
Creatinine	1.36	1.11	1.07		0.94		0.78		0.80	0.58
ALT	949	668	418	296	216	170	122	86	69	213
AST	1208	338	107	77	40	28	18	17	14	45
LD	1784	957	832	769	635	565	462	363	283	161
Ferritin	896	596	421	376	336				347
CRP	23.1	9.1	4.1	2.1	1.1	0.6			0.8	0.4

Back to the Article

Three Cases of COVID-19 Pneumonia That Responded to Icosapent Ethyl Supportive Treatment

Your Privacy